BioCentury
ARTICLE | Strategy

Sequana's plans with Sloan-Kettering

August 26, 1996 7:00 AM UTC

Memorial Sloan-Kettering Cancer Center, which has long been active as a major clinical research center, took its first step into the formal business of biotech, forming an as-yet unnamed startup company with Sequana Therapeutics Inc.

After looking at several genomics companies, Sloan-Kettering approached SQNA to form a joint venture, according to SQNA President and CEO Kevin Kinsella...